Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Pelvic Malignancy”

153 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 153 results

Testing effectiveness (Phase 2)Study completedNCT00066352
What this trial is testing

Bortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or Ureter

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter
University Health Network, Toronto
Testing effectiveness (Phase 2)Study completedNCT00066612
What this trial is testing

S0306, Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With Chemotherapy

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
SWOG Cancer Research Network 45
Testing effectiveness (Phase 2)Study completedNCT00407485
What this trial is testing

VEGF Trap in Treating Patients With Recurrent, Locally Advanced, or Metastatic Cancer of the Urothelium

Who this might be right for
Adenocarcinoma of the BladderDistal Urethral CancerMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter+10 more
National Cancer Institute (NCI) 22
Early research (Phase 1)Looking for participantsNCT05412082
What this trial is testing

SMART TNT for the Conservative Management of Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer
University of Miami 25
Early research (Phase 1)WithdrawnNCT00118300
What this trial is testing

Capecitabine and Radiation Therapy in Treating Patients With Locally Advanced Cervical Cancer or Other Pelvic Cancer

Who this might be right for
Cervical CancerEndometrial CancerOvarian Cancer+1 more
Case Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT01844947
What this trial is testing

Phase I Study With Sorafenib in Addition to Vinflunine in Metastatic Transitional Cell Carcinoma of the Urothelial Tract

Who this might be right for
Urothelial CarcinomaBladder CancerRenal Pelvis Cancer+2 more
Dr Anders Ullén 22
Early research (Phase 1)Looking for participantsNCT04169763
What this trial is testing

Nelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar Cancer That Cannot Be Removed by Surgery

Who this might be right for
Stage II Vulvar Cancer AJCC v8Stage III Vulvar Cancer AJCC v8Stage IIIA Vulvar Cancer AJCC v8+3 more
M.D. Anderson Cancer Center 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT03237780
What this trial is testing

Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metastatic Urothelial Cancer

Who this might be right for
Locally Advanced Bladder Urothelial CarcinomaLocally Advanced Renal Pelvis Urothelial CarcinomaLocally Advanced Ureter Urothelial Carcinoma+21 more
National Cancer Institute (NCI) 72
Not applicableUnknownNCT04948879
What this trial is testing

The Role of Vascular Reconstruction in the Setting of Pelvic Exenteration

Who this might be right for
Vascular Reconstruction in Pelvic Exenterative Surgery
St Vincent's University Hospital, Ireland 100
Testing effectiveness (Phase 2)Study completedNCT00112671
What this trial is testing

Sorafenib in Treating Patients With Advanced or Metastatic Cancer of the Urinary Tract

Who this might be right for
Metastatic Transitional Cell Cancer of the Renal Pelvis and UreterRecurrent Bladder CancerRecurrent Transitional Cell Cancer of the Renal Pelvis and Ureter+4 more
National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)WithdrawnNCT03834571
What this trial is testing

Testing the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervical Cancer in HIV-positive Women

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise Specified+4 more
AIDS Malignancy Consortium
Testing effectiveness (Phase 2)Active Not RecruitingNCT04940299
What this trial is testing

Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Locally Advanced Bladder Carcinoma+39 more
M.D. Anderson Cancer Center 35
Testing effectiveness (Phase 2)Study completedNCT02459119
What this trial is testing

Study of Regorafenib for Urothelial Cancer Following Chemotherapy (UAB 1477)

Who this might be right for
Urothelial Cancer (Urinary Bladder, Ureters, or Renal Pelvis Cancer)
University of Alabama at Birmingham 17
Not applicableUnknownNCT04953377
What this trial is testing

PFMT Educational Intervention for Patients With Advancer Breast Cancer

Who this might be right for
Advanced Breast Cancer
Onkologikoa 42
Testing effectiveness (Phase 2)UnknownNCT02835404
What this trial is testing

Pelvic External Combined With 252-Cf Neutron Intracavitary Radiotherapy With or Without Platinum in Treating Advanced Cervical Cancer

Who this might be right for
Cervical CancerComplications
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 200
Not applicableStudy completedNCT03947268
What this trial is testing

Radiotherapy in Palliation of Advanced Pelvic Cancer

Who this might be right for
Palliative Care
IRCCS Azienda Ospedaliero-Universitaria di Bologna 25
Testing effectiveness (Phase 2)Study completedNCT00661609
What this trial is testing

A Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) in Advanced Bladder Cancer

Who this might be right for
Bladder CancerTransitional Cell Bladder CancerUrethra Cancer+2 more
AstraZeneca 54
Not applicableLooking for participantsNCT05186493
What this trial is testing

Laparoscopic Robot-assisted Pelvic Exenteration for Pelvic Primary and Recurrent Cancers

Who this might be right for
Locally Advanced Pelvic Cancer That Require Pelvic Exenteration
Oslo University Hospital 40
Early research (Phase 1)Study completedNCT01485731
What this trial is testing

Safety Study of Nelfinavir + Cisplatin + Pelvic Radiation Therapy to Treat Cervical Cancer

Who this might be right for
Cervical Cancer
University of Miami 8
Testing effectiveness (Phase 2)Ended earlyNCT00112905
What this trial is testing

Sorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium

Who this might be right for
Adenocarcinoma of the BladderDistal Urethral CancerMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter+10 more
National Cancer Institute (NCI) 27
Load More Results